BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 16968719)

  • 1. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
    Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine experience in nephrotic syndrome.
    Phadke K; Ballal S; Maiya V
    Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
    Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
    Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
    Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
    Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
    Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
    Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
    Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Shuto H; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.